IL91015A - Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans - Google Patents

Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans

Info

Publication number
IL91015A
IL91015A IL9101589A IL9101589A IL91015A IL 91015 A IL91015 A IL 91015A IL 9101589 A IL9101589 A IL 9101589A IL 9101589 A IL9101589 A IL 9101589A IL 91015 A IL91015 A IL 91015A
Authority
IL
Israel
Prior art keywords
alkyl
denotes
dimethyl
dihydro
disorders
Prior art date
Application number
IL9101589A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL91015A publication Critical patent/IL91015A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL9101589A 1988-07-19 1989-07-18 Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans IL91015A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824446A DE3824446A1 (de) 1988-07-19 1988-07-19 Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege

Publications (1)

Publication Number Publication Date
IL91015A true IL91015A (en) 1994-11-28

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9101589A IL91015A (en) 1988-07-19 1989-07-18 Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans

Country Status (18)

Country Link
EP (2) EP0351720B1 (pt)
JP (1) JPH0273015A (pt)
KR (1) KR900001367A (pt)
AT (1) ATE110270T1 (pt)
AU (1) AU621388B2 (pt)
CA (1) CA1336891C (pt)
CZ (1) CZ417091A3 (pt)
DE (2) DE3824446A1 (pt)
DK (1) DK171782B1 (pt)
ES (1) ES2061816T3 (pt)
FI (1) FI893460A7 (pt)
HU (1) HU210149B (pt)
IE (1) IE63872B1 (pt)
IL (1) IL91015A (pt)
NZ (1) NZ229961A (pt)
PH (1) PH26696A (pt)
PT (1) PT91197B (pt)
ZA (1) ZA895459B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (pt) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (pt) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
WO2001047491A1 (en) * 1999-12-23 2001-07-05 Coifman Robert E Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (ko) * 2002-09-09 2005-03-10 정의상 알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
DE60323533D1 (de) 2002-11-12 2008-10-23 Warner Lambert Co Methode zur stimulierung von haarwuchs auf der basis von benzopyranen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
EP0277611B1 (de) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
CA1336891C (en) 1995-09-05
FI893460A7 (fi) 1990-01-20
JPH0273015A (ja) 1990-03-13
CZ417091A3 (en) 1993-02-17
AU3818989A (en) 1990-01-25
HUT55988A (en) 1991-07-29
HU210149B (en) 1995-02-28
FI893460A0 (fi) 1989-07-17
EP0560399A1 (de) 1993-09-15
ES2061816T3 (es) 1994-12-16
EP0351720B1 (de) 1994-08-24
DK355489A (da) 1990-01-20
PT91197B (pt) 1995-07-18
KR900001367A (ko) 1990-02-27
EP0351720A2 (de) 1990-01-24
EP0351720A3 (de) 1992-01-02
NZ229961A (en) 1991-11-26
DE58908228D1 (de) 1994-09-29
PT91197A (pt) 1990-02-08
ATE110270T1 (de) 1994-09-15
ZA895459B (en) 1990-03-28
DE3824446A1 (de) 1990-01-25
IE892323L (en) 1990-01-19
PH26696A (en) 1992-09-15
AU621388B2 (en) 1992-03-12
DK355489D0 (da) 1989-07-18
DK171782B1 (da) 1997-05-26
IE63872B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
JP2793195B2 (ja) ベンゾチアゾール誘導体
US5403842A (en) Benzopyran and benzothiopyran derivatives
PL141134B1 (en) Method of manufacture of novel benzopyranes
US5955495A (en) Method of treating diseases of the CNS
US4999371A (en) Substituted 3,4-dihydro-2H-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
HUT54673A (en) Process for producing benzopirane derivatives and pharmaceutical compositions containing them as active components
AU653245B2 (en) Novel benzopyran derivatives
US5206252A (en) Thiadiazolyl-amino derivatives of benzopyrans and indanes
US4960778A (en) Benzoxazolinone compounds
FI95250B (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
DK166540B1 (da) Dibenzoeb,eaaoxepinderivater, fremgangsmaader til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne samt anvendelse af forbindelserne
IL91015A (en) Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans
US5364878A (en) Use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs
US5278158A (en) Oxazinobenzazole compounds
EP0147691B1 (en) Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl and-sulfinyl-alkanoic acids, a process for their preparation and their use for the preparation of medicaments
HUT53631A (en) Process for producing deacetyl-forscholine-7-aryl and -heteroaryl ethers and pharmaceutical compositions comprising such compounds
GB2214183A (en) Ergoline derivatives
JPH02101074A (ja) ６‐アロイル‐置換３，４‐ジヒドロ‐２ｈ‐ベンゾピランおよびその製造方法
JPH0699308B2 (ja) ヒダントイン誘導体を有効成分とする循環器系疾患の予防及び治療剤並びに循環器系疾患と糖尿病合併症の同時的予防及び治療剤

Legal Events

Date Code Title Description
RH Patent void